WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

G GENITO URINARY SYSTEM AND SEX HORMONES
G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM

Other hormones, see H - Systemic hormonal preparations, excl. sex hormones and insulins.

Sex hormones used only in the treatment of cancer (often selected strengths) are classified in L - Antineoplastic and immunomodulating agents.

The DDDs of many of the hormone preparations may vary considerably with the route of administration due to substantial differences in bioavailability. The DDDs of depot preparations are calculated as the dose divided by the dosing interval.


G03G GONADOTROPINS AND OTHER OVULATION STIMULANTS

The DDDs are based on the initial treatment of anovulation.


G03GA Gonadotropins

This group comprises both naturally occurring gonad-stimulating hormones and synthetic ovulation stimulants.

G03GA02 comprises products of human origin (e.g. menotrophin) while G03GA30 comprises combinations of recombinant hormones (e.g. follitropin alfa and lutropin alfa).


    ATC code  Name  DDD  U Adm.R Note
    G03GA06 follitropin beta 75 

List of abbreviations

Last updated: 2017-12-20